DJIA 17,060.59 -37.86 -0.22%
NASDAQ 4,588.95 8.68 0.19%
S&P 500 2,003.59 0.22 0.01%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

59.82 -0.29 (-0.48%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $59.83 -0.47%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.73
Previous Close $60.11
Daily Range $59.73 - $60.10
52-Week Range $44.62 - $60.58
Market Cap $172.6B
P/E Ratio 31.64
Dividend (Yield) $1.76 (2.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,222,555
Average Daily Volume 7,863,340
Current FY EPS $3.49





Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary Rss Feed

Great Cholesterol Drug Data From Regeneron Pharmaceuticals Inc. and Sanofi SA, but Read the Fine Pri

Regeneron Pharmaceuticals and Sanofi's PCSK9 drug, alirocumab, reduces cardiovascular events, but the data come from a post-hoc analysis.

Top-Yielding Stocks Dominate UBS Equity Focus List for September

S.Korea lifts ban on beef with feed additive -food ministry

Market View For 2014 And 2015, The Investor's View

Bristol-Myers Squibb Gets European Approval For HCV Drug Daklinza

IYH, PFE, MRK, UNH: ETF Inflow Alert

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Dow Analyst Moves: MRK

I Am Sure This Pharma-Company Suits Your Portfolio

Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

See More MRK News...

MRK's Top Competitors

MRK $59.82 (-0.48%)
Current stock: MRK
JNJ $103.18 (-0.53%)
Current stock: JNJ
NVS $93.00 (3.52%)
Current stock: NVS
RHHBY $36.41 (-0.27%)
Current stock: RHHBY